Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Signet Accel Appoints Dr. Philip Payne as Chief Science Officer

Signet Accel
Posted on: 25 Aug 16

Leading software and services company Signet Accel announced today that Dr. Philip Payne has been appointed to its executive team as Chief Science Officer (CSO). As one of the company’s co-founders and creators of its flagship product Avec®, a federated data integration platform, Dr. Payne will lead product development, support clients in solution strategy and development, and direct ongoing thought leadership for the company.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160825005855/en/

Dr. PhilipPayne, newly appointed CSO at Signet Accel. (Photo: Business Wire)

"Delivering successful technologies in a complex environment like healthcare requires us to achieve a critical balance between technology and the people who use those technologies,” Dr. Payne said. “As Chief Science Officer, I have the privilege to work with both our engineering team and our clients to ensure the platforms and tools we deliver are at the leading edge, advancing research, clinical care, and population health through the realization of true interoperability.”

Also Professor and inaugural Director of the Institute for Informatics at Washington University School of Medicine, the CSO position will be a dual role for Dr. Payne. A leader in both the academic and business sectors, Payne serves as a bridge builder in his new capacity.

“As both a researcher and an informaticist, and an innovator at heart, Dr. Payne provides valuable insight into the voice and needs of our clients,” said John Raden, Signet Accel CEO. “Dr. Payne’s appointment represents another key milestone in the company's history and level of maturity. We’re looking forward to his continued leadership as Avec evolves.”

Avec connects and harmonizes disparate databases across healthcare verticals, allowing researchers to identify patterns and trends over a large patient population and offering comprehensive insight into both research and patient treatment. Robust repositories of connected data are a key resource in realizing the promise of precision medicine, a research effort aimed at improving health and treating disease by accounting for patients’ individual differences.

As a software and services company specializing in data integration and harmonization, Signet Accel brings true interoperability to healthcare data and increased speed of discovery to translational medicine.

About Signet Accel

Signet Accel’s Avec® platform is true interoperability realized in healthcare. As the sole alternative to traditional, centralized data management solutions, Avec® delivers the industry's only purpose-built commercial federated data integration platform, developed and refined over 12 years at The Ohio State University. Signet Accel’s software products and services power the work of consortia, institutions, and health professionals around the world with unmatched security, sharing capability and speed of discovery —advancing academic research, achieving meaningful use objectives, and enabling the continuum of care. Learn how to make your data meaningful and achieve true interoperability at SignetAccel.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160825005855/en/

Business Wire
www.businesswire.com

Last updated on: 25/08/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.